Drug–drug interaction potential in men treated with enzalutamide: Mind the gap

類似資料

• The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients
  著者:: Benoist, Guillemette E., 等
  出版事項: (2020)
• Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
  著者:: Benoist, Guillemette E., 等
  出版事項: (2016)
• Development and validation of a bioanalytical method to quantitate enzalutamide and its active metabolite N-desmethylenzalutamide in human plasma: application to clinical management of metastatic castration-resistant prostate cancer patients
  著者:: Benoist, Guillemette E, 等
  出版事項: (2018)
• A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics
  著者:: Lubberman, Floor J. E., 等
  出版事項: (2019)
• A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration‐resistant metastatic prostate cancer
  著者:: Benoist, Guillemette E., 等
  出版事項: (2018)